Search research articles
Contact Us
Filters
Showing results (561-570 of 591) with videos related to
Page
of 60
Sort By:
The Journal of Urology
|
September 23, 2003
Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience
Ken-Ryu Han, Jeff K Cohen, Ralph J Miller, et al.
The Journal of Urology
|
June 15, 2013
The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study
Claus G Roehrborn, Steven N Gange, Neal D Shore, et al.
The Canadian Journal of Urology
|
June 13, 2015
Three year results of the prostatic urethral L.I.F.T. study
Claus G Roehrborn, Daniel B Rukstalis, Jack Barkin, et al.
The Canadian Journal of Urology
|
June 26, 2017
Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study
Claus G Roehrborn, Jack Barkin, Steven N Gange, et al.
Cancer
|
March 11, 2020
Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data
Celestia S Higano, Andrew J Armstrong, Oliver Sartor, et al.
The New England Journal of Medicine
|
June 1, 2026
Perioperative Apalutamide in High-Risk Localized Prostate Cancer
Mary-Ellen Taplin, Martin Gleave, Neal D Shore, et al.
Prostate Cancer and Prostatic Diseases
|
March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
Oliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.
Cancer
|
December 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials
Georges Gebrael, Neeraj Agarwal, Alicia K Morgans, et al.
The Journal of Urology
|
August 26, 2021
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial
K Kent Chevli, Neal D Shore, Andrew Trainer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 26, 2020
CD8<sup>+</sup> T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens
Neal D Shore, Matthew P Morrow, Trevor McMullan, et al.
Page
of 60
Search research articles
Search
Showing results (561-570 of 591) with videos related to
Sort By:
Page
of 60
The Journal of Urology
|
September 23, 2003
Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience
Ken-Ryu Han, Jeff K Cohen, Ralph J Miller, et al.
The Journal of Urology
|
June 15, 2013
The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study
Claus G Roehrborn, Steven N Gange, Neal D Shore, et al.
The Canadian Journal of Urology
|
June 13, 2015
Three year results of the prostatic urethral L.I.F.T. study
Claus G Roehrborn, Daniel B Rukstalis, Jack Barkin, et al.
The Canadian Journal of Urology
|
June 26, 2017
Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study
Claus G Roehrborn, Jack Barkin, Steven N Gange, et al.
Cancer
|
March 11, 2020
Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data
Celestia S Higano, Andrew J Armstrong, Oliver Sartor, et al.
The New England Journal of Medicine
|
June 1, 2026
Perioperative Apalutamide in High-Risk Localized Prostate Cancer
Mary-Ellen Taplin, Martin Gleave, Neal D Shore, et al.
Prostate Cancer and Prostatic Diseases
|
March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
Oliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.
Cancer
|
December 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials
Georges Gebrael, Neeraj Agarwal, Alicia K Morgans, et al.
The Journal of Urology
|
August 26, 2021
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial
K Kent Chevli, Neal D Shore, Andrew Trainer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 26, 2020
CD8<sup>+</sup> T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens
Neal D Shore, Matthew P Morrow, Trevor McMullan, et al.
Page
of 60